The Penington Institute describes Australia's record drug-induced deaths as the result of policy failure that has left harm reduction underfunded, and calls for a balanced approach that responds to complex and emerging harms.
EHRA argues that debates over different naloxone formulations in the EECA region distract from the barriers preventing it from reaching the people most likely to witness an overdose.
Gilmour et al. find no statistically observable impact of Oregon’s drug decriminalisation policy on opioid overdose mortality, challenging claims that the reform caused the state’s rise in deaths.
The conference will together people with lived and living experience, policymakers, service providers, and health and social care professionals to explore responses to drug-related deaths and harms.
Singh Kelsall et al. find that harmful policing practices persisted during British Columbia’s decriminalisation pilot and subsequent recriminalisation, including confiscations, displacement and interference with overdose response.
Research-backed harm reduction programmes in New York City have reversed nearly 2,000 overdoses and reduced fatalities, even as federal funding cuts threaten their survival.
Public health officials warn that the Trump administration’s budget cuts and staff reductions could derail national progress against the opioid crisis by jeopardizing addiction services, treatment, and lifesaving overdose-prevention programs.
Scotland’s "Stop the Deaths" conference highlighted a critical gap where evidence-based policies like safe consumption rooms and same-day treatment struggle to keep pace with a public health emergency, claiming over 1,000 lives annually.
